We’re confident our clinically driven AI and medical knowledge leads the industry and we welcome scientific scrutiny.

Daniel Nathrath

I look forward to a more collaborative future for health and tech, working together to improve access to healthcare.

Better together: Collaborating with healthcare organizations around the world in the fight against COVID-19

Daniel has nearly 20 years' experience leading the charge to bring transformational technology to new industries. During his career, he has founded and led several internet startups based in Denmark, Germany, the US, and the UK. After studying law as a Fulbright Scholar at the University of Houston, Daniel earned his MBA at the University of Chicago, then shifted his focus to consulting at Boston Consulting Group before embarking on his entrepreneurial journey.

Daniel is Ada’s Chief Executive Officer and one of our co-founders.

{COUNT, plural, one{Medical reviewer} other{Medical reviewers}}:

Share this article:

{COUNT, plural, one{Transcreator} other{Transcreators}}:

{COUNT, plural, one{Writer} other{Writers}}:

Ada Editorial

Editorial

Topics

Medically reviewed articles:

Transcreated articles:

Written articles:

We use technically required and functional cookies on our website in order to provide you with a user-friendly, secure, and effective website. With your consent, we also use third-party cookies and other tools for analytical and marketing purposes in certain areas, for example to assess the effectiveness of our marketing measures. For this, certain events of your use of the website will be shared with the respective providers. By clicking ‘accept’, you consent to the use of all cookies and tools. You can withdraw or adjust your consent at any time via the Cookie Settings in the footer of this website. This does not affect the legality of the processing of your data up to that point. Read our Cookie Policy and our Privacy Policy to learn more.

We use cookies on our website in order to help provide you with a user-friendly, secure, and effective website. We also use third-party cookies and other tools for analytical and marketing purposes in certain areas, for example to assess the effectiveness of our marketing measures. For this, certain events of your use of the website will be shared with the respective providers. You may visit the Cookie Settings in the footer of this website at any time to withdraw your consent and manage your rights concerning the selling or sharing of your data. Read our Privacy Policy to learn more.

Read our Cookie Policy and our Privacy Policy to learn more.

To exercise your right to opt-out of selling or sharing your personal information you need to deselect both “Statistic and performance” and “Marketing” cookies. Read our Privacy Policy to learn more.

Marketing cookies and tools are used to track visitors across websites. The intention is to target advertising and measure the effectiveness of our campaigns. For this, selected events of your use of this website will be shared with the providers of these cookies or tools. For users from the US, we currently use pixels by Meta Platforms Inc., Google LLC and Microsoft Corp. For all other users, we only use the pixel by Meta Platforms Ireland Ltd. Please consider opting-in.

Marketing

Necessary cookies are essential to provide you with our Services. It enables basic functions like page navigation and access to secure areas of the Services. You cannot opt-out of this.

Necessary

Statistic and performance cookies help website owners to understand how visitors interact with websites by collecting and reporting usage information. We recommend opting-in.

Statistics and performance

Cookie Settings

This website uses cookies. Read our Cookie Policy and our Privacy Policy to learn more.

COVID-19 Risk Severity and Treatment Eligibility

There are currently no items in your cart.
Find some.

Daniel Nathrath

Written articles:

An update from Daniel

Better together: Collaborating with healthcare organizations around the world in the fight against COVID-19